Seelos Therapeutics, Inc.
SEEL
Revenue
376.00k
▼-203.00k▼-35.06%
3 Months ChangeAssets
2.38M
▼-1.23M▼-34.08%
3 Months ChangeLiabilities
30.51M
▼-6.20M▼-16.89%
3 Months ChangeFree Cash Flow
-6.13M
▲164.00k▲2.61%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-24
Form 8-K
ID: 0001104659-24-111155
2024-10-15
Form 8-K
ID: 0001104659-24-108396
2024-10-07
Form 8-K
ID: 0001104659-24-106406
2024-09-26
Form 8-K
ID: 0001104659-24-103143
2024-09-25
Form 8-K
ID: 0001104659-24-102625
2024-09-24
Form 8-K
ID: 0001104659-24-102434
2024-09-03
Form 8-K
ID: 0001104659-24-096067
2024-08-14
Form 10-Q
ID: 0001410578-24-001435
2024-08-08
Form 8-K
ID: 0001140361-24-036392
2024-07-26
Form 8-K
ID: 0001104659-24-083012